Imide derivatives ar Salts thereof

Abstract

An amide derivative represented by the following formula: wherein the ring B is a heteroaryl group; X is a bond or a lower alkylene group; and R is a hydrogen atom, a halogen atom, a lower alkyl group, an amino group, an aryl lower alkyl group or a haloaryl lower alkyl group, or a salt thereof, is disclosed. A therapeutic agent for diabetes mellitus having both an insulin secretion promoting action and an insulin sensitivity potentiating action and also having anti-obesity and anti-hyperlipemia actions due to a selective stimulating action to beta3-receptors, is also disclosed.

Description

technical field [0001] The present invention relates to a class of medicines, more specifically to novel amide derivatives or their salts and therapeutic agents for treating diabetes. Background technique [0002] Diabetes mellitus, a disease accompanied by symptoms of persistent hyperglycemia, is now thought to be due to a number of environmental and genetic factors. The main control factor of blood sugar is insulin, and it has been recognized that hyperglycemia is caused by a lack of insulin or an excess of factors that inhibit insulin response (such as genetic reasons, lack of exercise, obesity and stress). [0003] There are two main types of diabetes. One is insulin-dependent diabetes mellitus (IDDM) caused by autoimmune diseases that reduce the function of pancreas to secrete insulin, and the other is non-insulin-dependent diabetes mellitus (IDDM) that is caused by the fatigue of continuous high-level secretion of insulin by the pancreas, which reduces the function of...

AI Technical Summary

Problems solved by technology

However, the patent does not indicate that these compounds have the effect of promoting insulin secretion and enhancing insulin sensitivity

Images